Theravance Biopharma (TBPH) Misses Q1 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. COIN
4. PINS
5. RDDT
6. FSLR
7. GILD
8. SNDK
9. FND
10. DASH

Go back to Theravance Biopharma (TBPH) Misses Q1 EPS by 13c

Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

May 7, 2019 4:06 PM EDT

DUBLIN, May 7, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the first quarter ended March 31, 2019. Revenue for the first quarter of 2019 was $5.3 million. First quarter operating loss was $73.7 million or $61.4 million excluding share-based compensation expense. Cash, cash equivalents, and marketable securities totaled $434.1 million as of March 31, 2019.

... More